Cell Proliferation in B Malignant Lymphomas: Comparison with Other Biological Characteristics and Prognostic Significance

References

• Cooper E. H., Peckham M. J., Millard R. E., Hamlin I. M. E., Gerard-Marchand R. Cell proliferation in Human Malignant Lymphomas. Analysis of Labelling Index and DNA content in cell populations obtained by biopsy. Europ., J., Cancer 1968; 4: 287–96
   PubMedGoogle Scholar
• Costa A., Bonadonna G., Villa E., Valagussa P., Silvestrini R. Labelling index as a prognostic marker in non-Hodgkin's lymphomas. J.N.C.I 1981; 66: 1–5
   PubMed Web of Science ®Google Scholar
• Silvestrini R., Costa A., Giardini R., Boracchi P., Del Bino G., Marubini E., Rilke F. Prognostic implications of cell kinetics, histopathology and pathologic stage in non-Hodgkin's lymphomas. Hematol. Oncol 1989; 7: 411–22
   PubMed Web of Science ®Google Scholar
• Shackney S E., Skramstad K. S., Cunningham R. E., Dugas D. J., Lincoln T. L., Lukes R. J. Dual parameter flow cytometry studies in human lymphomas. J. Clin. Invest 1980; 66: 1281–94
   PubMed Web of Science ®Google Scholar
• Braylan R. C., Benson N. A., Nourse V. A. Cellular DNA of human neoplastic B-cells measured by flow cytometry. Cancer Res 1984; 44: 5010–16
   PubMed Web of Science ®Google Scholar
• Srigley J., Barlogic B., Butler J. J., Osborne B., Blick M., Johnston D., Kantarjian H., Reuben J., Batsakis J., Freireich E. J. Heterogeneity of non-Hodgkin's lymphoma probed by nucleic acid cytometry. Blood 1985; 65: 1090–96
   PubMed Web of Science ®Google Scholar
• Christensson B., Tribukait B., Linder I., Ullman B., Biberfeld P. Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification. Cancer 1986; 58: 1295–1304
   PubMed Web of Science ®Google Scholar
• Bauer K. D., Merkel D. E., Winter J. N., Marder R. J., Hauck W. W., Wallemark C. B., Williams T. J., Variakojis D. Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas. Cancer Res 1986; 46: 3173–78
   PubMed Web of Science ®Google Scholar
• Wooldridge T. N., Grierson H. L., Weisenburger D. D., Armitage J. O., Sanger W. G., Collins M. M., Pierson J. L., Pauza M. E., Fordyce R., Purtilo D. T. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma. Cancer Res 1988; 48: 6608–13
   PubMed Web of Science ®Google Scholar
• McLaughlin P., Osborne B., Johnston D., Jennings P., Butler J. J., Cabanillas F., Barlogic B. Nucleic acid flow cytometry in large cell lymphoma. Cancer res 1988; 48: 6614–19
   PubMed Web of Science ®Google Scholar
• The non-Hodgkin's lymphoma pathologic classification project. National cancer institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a Working Formulation for clinical usage. Cancer 1982; 49: 2112–35
   PubMed Web of Science ®Google Scholar
• Weisenburger D. D., Nathwani B. N., Diamond L. W., Winberg C., Rappaport H. Malignant lymphoma, intermediate lymphocytic type: a clinico-pathologic study of 42 cases. Cancer 1981; 48: 1415–25
   PubMed Web of Science ®Google Scholar
• Coiffier B., Bryon P. A., Ffrench M., Blane M., Sebban C., Berger F., Viala J. J. Intensive chemotherapy in aggressive lymphomas: update results of LNH-80 protocol and prognostic factors affecting response and survival. Blood 1987; 70: 1394–99
   PubMed Web of Science ®Google Scholar
• Ffrench M., Bryon P. A., Fiere D., van Vu H., Gentilhomme O., Adeleine P., Viala J. J. Cell cycle, protein content and nuclear size in acute myeloid leukaemia. Cytometry 1985; 6: 47–53
   PubMedGoogle Scholar
• Baisch H., Gohde W., Linden W. A. Mathematical analysis of ICP-data to determine the fraction of cells in the various phases of cell-cycle. Pulse Cytometry, Part I, C. M. A. Haanen, H. F. P. Hillen, J. M. C. Wessels. European Press publishers., Ghent 1975; 68–76
   Google Scholar
• Rehn S., Glimelius B., Strang P., Sundström C., Tribukait B. Prognostic significance of flow cytometry studies in B-cell non-Hodgkin's lymphoma. Hematol. Oncol 1990; 8: 1–12
   PubMed Web of Science ®Google Scholar
• Wain S. L., Braylan R. C., Borowitz M. J. Correlation of monoclonal antibody phenotyping and cellular DNA content in Non-Hodgkin's Lymphoma. Cancer 1987; 60: 2403–11
   PubMed Web of Science ®Google Scholar
• Tedder T. F., Forsgren A., Boyd W. A., Nadler L. N., Schlossman S. F. Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes. Eur. J. Immunol 1986; 16: 881–7
   PubMed Web of Science ®Google Scholar
• Bubien J. K., Bell P. D., Frizzell R. A., Tedder T. F. CD 20 directly regulates transmembrane ion flux in B-lymphocytes. Leucocyte typing IV; White cell differentiation antigens, W. Knapp, B. Dörken, W. R. Gilks. Oxford University Press Publishers. 1989; 51–54
   Google Scholar
• Pirruccello S. J., Bicak M. S. Biochemical characterisation of the CD 24 antibody panel and cell-cycle studies of CD 24 antigen expression on pre-B-ALL cell lines. Leucocyte typing IV; White cell differentiation antigens, W. Knapp, B. Dörken, W. R. Gilks. Oxford University Press Publishers. 1989; 83–84
   Google Scholar
• Lanier L. L., Warner N. L. Cell cycle related heterogeneity of la antigen expression on a murine B cell line: analysis by flow cytometry. J. Immunol 1981; 126: 626–31
   PubMed Web of Science ®Google Scholar
• Ffrench M., Magaud J. P., Manel A. M., Adeleine P., Devaux Y., Fiere D., Philippe N., Souillet G., Bryon P. A. Cell kinetics in acute lymphoblastic leukaemia: comparative analysis between adults and children. Br. J. Cancer 1989; 59: 401–6
   PubMed Web of Science ®Google Scholar
• Ffrench M., Magaud J. P., Arzounian M., Souchier C., Charrin C., Bryon P. A. Is there an accumulation of cells during G2 in some acute lymphoblastic leukaemia?. Cell Tissue Kinet 1990; 23: 251–60
   PubMedGoogle Scholar
• Iversen O. H., Iversen U., Ziegler J. L., Bluming A. Z. Cell kinetics in Burkitt lymphoma. Europ. J. Cancer 1974; 10: 155–63
   PubMed Web of Science ®Google Scholar
• Kung A. L., Zetterberg A., Sherwood S. W., Schimke R. T. Cytotoxic effects of cell cycle phase specific agents; result of cell cycle perturbation. Cancer res 1990; 50: 7307–17
   PubMed Web of Science ®Google Scholar
• Duvall E., Wyllie A. H. Death and the cell. Immunol. Today 1986; 7: 115–19
   PubMedGoogle Scholar
• Vaux D. L., Cory S., Adams J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440–442
   PubMed Web of Science ®Google Scholar
• Williams G. T., Smith C. A., Spooncer E., Dexter T. M., Taylor D. R. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 1990; 343: 76–79
   PubMed Web of Science ®Google Scholar
• Gregory C. D., Dive C., Henderson S., Smith C. A., Williams G. T., Gordon J., Rickinson A. B. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991; 349: 612–14
   PubMed Web of Science ®Google Scholar